Document is current
Any future updates will be listed below
-
Authors
Meffert, Jan H. https://orcid.org/0000-0003-4342-5618
Lopes, Mónica
Cadoni, Enrico https://orcid.org/0000-0001-5585-7579
Bollmark, Martin https://orcid.org/0000-0002-3715-1959
Tedebark, Ulf
Madder, Annemieke https://orcid.org/0000-0003-0179-7608
-
Funding
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (Grant Agreement No. 956070 (OLIGOMED))
Fonds Wetenschappelijk Onderzoek (FWO I006920N)
Bijzonder Onderzoeksfonds (BOF.BAS.2022.0023.01)
- License Information
-
More Information
Article History
Received: 31 July 2025
Accepted: 26 December 2025
First Online: 10 January 2026
Competing interests
: Annemieke Madder has a pending patent application relating to 5HP2Os application for bioconjugation (Bioconjugation reagent and methods, WO2020174086A2, Annemieke MADDER, Ewout DE GEYTER, Eirini ANTONATOU, Sabina SMOLEN, Dimitris Kalaitzakis, Georgios VASSILIKOGIANNAKIS, Europe&US). All other authors declare no competing interest.
